CanSinoBIO’s mRNA COVID-19 vaccine candidate cleared for clinical trials in China EP News Bureau Apr 5, 2022 Unlike other major countries, China is yet to approve any foreign-made mRNA vaccines such as that produced by American-German duo…
China CanSinoBIO’s vaccine 57.5 per cent effective against COVID in phase-III trial: Study Reuters Dec 24, 2021 The single-shot Ad5-nCoV vaccine, which CanSinoBIO co-developed with the Chinese military-backed Beijing Institute of…
Pakistan to conduct phase-III clinical trial of COVID-19 vaccine from CanSinoBio Press Trust of India Aug 18, 2020 The NIH said this would be the first-ever phase-III clinical trial for any vaccine in Pakistan
